Lv11
46 积分 2025-03-12 加入
Design and Activity of Specific Hypoxia-Inducible Factor-2α (HIF-2α) Inhibitors for the Treatment of Clear Cell Renal Cell Carcinoma: Discovery of Clinical Candidate (S)-3-((2,2-Difluoro-1-hydroxy-7-(methylsulfonyl)-2,3-dihydro-1H-inden-4-yl)oxy)-5-fluorobenzonitrile (PT2385)
3小时前
已完结
Current state of immunotherapy for glioblastoma
14天前
已完结
Triple-Negative Breast Cancer
2个月前
已完结
Targeting ARPC1B Overcomes Immune Checkpoint Inhibitor Resistance in Glioblastoma by Reversing Pro-tumorigenic Macrophage Polarization
5个月前
已完结
皖公网安备34019202002308
